Neuropalliative and rehabilitative care in patients with an advanced stage of progressive neurological diseases
Authors:
R. Bužgová 1; M. Bar 2,3; P. Bártová 2,3; R. Kozáková 1; P. Ressner 2,3; L. Sikorová 1; R. Zeleníková 1
Authors‘ workplace:
Ústav ošetřovatelství a porodní asistence, LF OU Ostrava
1; Neurologická klinika FN Ostrava
2; Katedra neurologie a psychiatrie, LF OU Ostrava
3
Published in:
Cesk Slov Neurol N 2018; 81(1): 17-23
Category:
Review Article
doi:
https://doi.org/10.14735/amcsnn201717
Overview
Patients with an advanced stage of progressive neurological diseases belong to the group of patients who may be eligible for palliative care. The aim of this review paper is to describe groups of patients eligible for palliative care and to analyze the number of hospitalizations in the last year of their life, their location and age of death. Furthermore, to describe the possibilities of using the concept of neuropalliative and rehabilitative care that is based on connecting the care of a neurology specialist, rehabilitation and palliative care services throughout the illness until the end of the patient’s life. Emphasis is placed on maintaining functional abilities, symptom management, providing comfort, maximizing the quality of life, and reducing the burden of the illness of the patient and his/ her family. An important part of the care is also the discussion of the end-of-life care plan, or transcribing a previously expressed wish. In foreign literature, neuropalliative care is described in patients with Parkinson disease, multiple sclerosis, amyotrophic lateral sclerosis, Huntington disease and atypical parkinsonism. The evaluation scales (GSF PIG, SPICT, NECPAL CCOMS-ICO) were used to identify patients who require any kind of palliative care. The criteria for the patient’s admission to hospice care are also pointed out.
Key words:
quality of life – palliative care – rehabilitation – death
The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.
The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.
Sources
1. Radbruch L, Payne S. White Paper on standards and norms for hospice and palliative care in Europe: part 1:recommendations from the European Association for Palliative Care. Eur J Palliat Care 2009; 16(6): 278– 289.
2. Pastrana T, Junger S, Ostgathe S et al. A matter of definition – key elements identified in a discourse analysis of definitions of palliative care. Palliat Med 2008; 22(3): 222– 232. doi: 10.1177/ 0269216308089803.
3. Seymour J. Co je v názvu? Pojmová analýza klíčových termínů v paliativní péči. In: Payne S, Seymour J, Ingleton CH et al. Paliativní péče: principy a praxe. Brno: Společnost pro odbornou literaturu 2007: 63– 83.
4. Sepúlveda C, Marlin A, Yoshida T et al. Palliative Care: The World Health Organization’s Global Perspective. J Pain Symptom Manage 2002; 24(2): 91– 96.
5. Boersma I, Miyasaki ME, Kutner J et al. Palliative care and neurology: time for a paradigm shift. Neurology 2014; 83(5): 561– 567. doi: 10.1212/ WNL.0000000000000674.
6. Skála B, Sláma O, Vorlíček J. Paliativní péče o pacienty v terminálním stádiu nemoci: doporučený diagnostický a léčebný postup pro všeobecné praktické lékaře, Praha: Společnost všeobecného lékařství ČLS JEP, Centrum doporučených postupů pro praktické lékaře 2011. Dostupné z URL: https:/ / www.paliativnimedicina.cz/ sites/ www.paliativnimedicina.cz/ files/ users/ simicek/ paliativni-pece-2011pro_pl.pdf.
7. Chahine LM, Malik B, Davis M. Palliative care needs of patients with neurologic or neurosurgical conditions. Eur J Neurol 2008; 15(12): 1265– 1272. doi: 10.1111/ j.1468-1331.2008.02319.x.
8. Friebert S, Williams C. NHPCO’s Facts and Figures: Pediatric Palliative & Hospice Care in America. Washington: National Hospice and Palliative Care Organization 2015. Available from URL: https:/ / www.nhpco.org/ sites/ default/ files/ public/ quality/ Pediatric_Facts-Figures.pdf.
9. Klinger CA, Howell D, Zakus D et al. Barriers and facilitators to care for the terminally ill: a cross-country case comparison study of Canada, England, Germany, and the United States. Palliat Med 2014; 28(2): 111– 120. doi: 10.1177/ 0269216313493342.
10. Švancara J, Sláma O, Kabelka L et al. Národní datová základna paliativní péče. Praha: Ústav zdravotnických informací ČR 2016. Dostupné z URL: http:/ / www.paliativnidata.cz.
11. Kala M. Neurologické diagnózy v diferencované hospicové péči – dvě kazuistiky. Cesk Slov Neurol N 2013; 76/ 109(6): 756– 758.
12. Borasio GD. The role of palliative care in patients with neurological disease. Nat Rev Neurol 2013; 9(5): 292– 295. doi: 10.1038/ nrneurol.2013.49.
13. Meier DE. Palliative care in hospitals. J Hospit Med 2006; 1(1): 21– 28. doi: 10.1002/ jhm.3.
14. Sláma O, Kabelka L, Špinková M. Paliativní péče v ČR v roce 2013. Praha a Brno: Perspektiva České společnosti paliativní medicíny ČLS JEP 2013.
15. van Vliet M, Gao W, Di Francesco D et al. How integrated are neurology and palliative care services? Results of a multicentre mapping exercise. BMC Neurol 2016; 16(10): 63. doi: 10.1186/ s12883-016-0583-6.
16. Fitzpatrick R, Peters M, Doll H et al. The needs and experiences of services by individuals with long-term progressive neurological conditions and their carers: a benchmarking study. Oxford: University of Oxford 2010.
17. Aarsland D, Larsen JP, Karlsen K et al. Mental symptoms in Parkinson‘s disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999; 14(10): 866– 874.
18. Oliver DJ, Borasio GD, Caraceni A et al. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. Eur J Neurol 2016; 23(1): 30– 38. doi: 10.1111/ ene.12889.
19. Hussain J, Adams D, Campbell C. End-of-life care in neurodegenerative conditions: outcomes of a specialist palliative neurology service. Int J Palliat Nurs 2013; 19(4): 162– 169. doi: 10.12968/ ijpn.2013.19.4.162.
20. Růžička E. Neurodegenerativní onemocnění mozku. In: Bednařík J et al. Klinická neurologie I. Praha: Triton 2010: 541– 707.
21. Ridzoň P, Mazanec R. Paliativní péče u terminálních stavů chorob motorického neuronu (amyotrofické laterární sklerózy, progresivní bulbární paralýzy a progresivní svalové atrofie). Neurol praxi 2010; 11(1): 23– 26.
22. Havrdová E. Roztroušená skleróza. In: Bednařík Jet al. Klinická neurologie I. Praha: Triton 2010.
23. Hauser SL, Oksenberg JR. The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration. Neuron 2006; 52(1): 61– 76.
24. Lindop F, Brown L, Graziano M et al. Atypical Parkinsonism: Making the case for a neuropalliative rehabilitation approach. Int J Ther Rehab 2014; 21(4): 176– 182.
25. Turner-Stokes L, Sykes N, Silber E et al. From diagnosis to death: exploring the interface between neurology, rehabilitation and palliative care, in the management of people with long term neurological conditions. Clin Med 2007; 7(2): 129– 236.
26. Sutton L. Addressing palliative and end-of-life care needs in neurology. Brit J Neurosci Nurs 2008; 4(5): 235– 238. doi: doi.org/ 10.12968/ bjnn.2008.4.5.29323.
27. McNab E. Music therapy in progressive neurological disease: A neuropalliative rehabilitation perspective. Austr J Mus Ther 2010; 21: 59– 76.
28. Galvin M, Madden C, Maquire S et al. Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study. BMC Health Serv Res 2015; 15: 1– 8. doi: 10.1186/ s12913-015-1229-x.
29. Dallara A, Tolchin D. Emerging Subspecialties in Neurology: palliative care. Neurology 2014; 82(18): 640– 642. doi: 10.1212/ WNL.0000000000000453.
30. Krejčíková H. Dříve vyslovená přání: manuál nejen pro pacienty. Praha: Cesta domů 2016.
31. Matějek J, Závadová I. Dříve vyslovená přání: manuál pro lékaře. Praha: Cesta domů 2016.
32. Miyasaki JM, Long J, Mancini D et al. Palliative care for advanced Parkinson disease: an interdisciplinary clinic and new scale, the ESAS-PF. Parkinsonism Relat Disord 2012; 18 (Suppl 3): S6– S9. doi: 10.1016/ j.parkreldis.2012.06.013.
33. Hasson F, Kernohan WG, McLaughlin M et al. An exploration into the palliative and end-of-life experiences of cares of people with Parkinson disease. Palliat Med 2010; 24(7): 731– 736. doi: 10.1177/ 0269216310371414.
34. Higginson IJ, McCrone P, Hart SR et al. Is short-term palliative care cost effective in multiple sclerosis. A randomized phase II trial. J Pain Symptom Manage 2009; 38(6): 816– 826. doi: 10.1016/ j.painsymman.2009.07.002.
35. Edmonds P, Hart S, Wei Gao et al. Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service. Multiple Sclerosis 2010; 16(5): 627– 636. doi: 10.1177/ 1352458510364632.
36. Dufek M. Roztroušená skleróza – EDSS (Expanded disability status scale), tzv. Kurtzkeho škala. Neurol praxi 2012; 12 (Suppl G): 6– 9.
37. Strupp J, Romtzky V, Paed D et al. Palliative care for severely affected patients with multiple sclerosis: when and why? Results of a Delphi Survey of health care professionals. J Pall Med 2014; 17(10): 1128– 1136. doi: 10.1089/ jpm.2013.0667.
38. Higginson I, Voltz R, Haffenden S et al. EMSP toolkit on code of good practice. 2008. Available from z URL: www.emsp.org/ attachments/ article/ 134/ 1code08.pdf.
39. Andersen PM, Abrahams S, Boraio GD et al. The EFNS task force on diagnosis and management of amyotrophic lateral sclerosis. EFNS guidelines on the clinical management of ALS – revised report of an EFNS task force. Eur J Neurol 2012; 19(3): 360– 375. doi: 10.1111/ j.1468-1331.2011.0351.x.
40. Gómez-Batiste X, Martínez-Munoz M, Blay C et al. Identifying needs and improving palliative care of chronically ill patients: a community-oriented, population-based, public-health approach. Curr Opin Support Palliat Care 2012; 6: 371– 378. doi: 10.1097/ SPC.0b012e328356 aaed.
Labels
Paediatric neurology Neurosurgery NeurologyArticle was published in
Czech and Slovak Neurology and Neurosurgery
2018 Issue 1
Most read in this issue
- A neurological view on spondylodiscitis
- Parosmia and phantosmia in patients with olfactory dysfunction
- Assessment of cognitive functions using short repeatable neuropsychological batteries
- Test of gestures (TEGEST) for a brief examination of episodic memory in mild cognitive impairment